Industry Events
EnglishFrançaisEspañol中文العربية
EventsNewsInsightsOrganisers
Services
  • Event MarketingList, promote and grow your events to a global B2B audience.
  • Press ReleaseDistribute official announcements to industry professionals worldwide.
  • Speaker & SME PromotionShowcase expertise, get booked for keynotes, panels and masterclasses.
Subscribe
Speaker Sign InList Your Free Event
Industry Events

The world's most trusted B2B event discovery platform. Connecting industry professionals with the conferences, expos and summits that matter.

Explore & Services
  • Industry Events
  • News
  • Event Organisers
  • About Us
  • Our Services
  • Premium Organiser
  • Event Pro
  • Become a Speaker
  • Subscribe
Legal & Privacy
  • Terms
  • Privacy

© 2026 Industry Events Worldwide. All rights reserved.

VF103.4.
Industry Events

The world's most trusted B2B event discovery platform. Connecting industry professionals with the conferences, expos and summits that matter.

  • Industry Events
  • News
  • Event Organisers
  • About Us
  • Our Services
  • Premium Organiser
  • Event Pro
  • Become a Speaker
  • Subscribe
  • Terms
  • Privacy

© 2026 Industry Events Worldwide. All rights reserved.

VF103.4.
  • Events
  • News
  • Insights
  • Account
Industry Events
EnglishFrançaisEspañol中文العربية
EventsNewsInsightsOrganisers
Services
  • Event MarketingList, promote and grow your events to a global B2B audience.
  • Press ReleaseDistribute official announcements to industry professionals worldwide.
  • Speaker & SME PromotionShowcase expertise, get booked for keynotes, panels and masterclasses.
Subscribe
Speaker Sign InList Your Free Event
  1. Home
  2. News
  3. STAT+: AstraZeneca’s experimental COPD treatment posts strong results in late-stage studies

STAT News

STAT+: AstraZeneca’s experimental COPD treatment posts strong results in late-stage studies

An experimental COPD drug from AstraZeneca could prove competitive with existing treatments, and have a slice of the market to itself.

Continue with the complete report on the publisher’s website.

Read full article at STAT News
S

By STAT News

8 September 2026|1 min read
Share
Health Tech
STAT+: AstraZeneca’s experimental COPD treatment posts strong results in late-stage studies
STAT+: AstraZeneca’s experimental COPD treatment posts strong results in late-stage studies
Share
← Back to IE News

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

  • STAT+: Inhibrx claims first win for long-sought immunotherapy target

    STAT News

    STAT+: Inhibrx claims first win for long-sought immunotherapy target

    8 September 2026
  • Disabled workers at greater risk of losing health insurance

    STAT News

    Disabled workers at greater risk of losing health insurance

    4 September 2026
  • STAT+: Not so fast: Diabetes association panel not done reviewing ejections from its June meeting

    STAT News

    STAT+: Not so fast: Diabetes association panel not done reviewing ejections from its June meeting

    7 September 2026
  • STAT+: FDA approves AstraZeneca breast cancer drug

    STAT News

    STAT+: FDA approves AstraZeneca breast cancer drug

    8 September 2026
  • STAT+: Oura files to goes public, reported $1.2B in earnings

    STAT News

    STAT+: Oura files to goes public, reported $1.2B in earnings

    8 September 2026
  • STAT+: Novo Nordisk stops two cardiovascular trials of drug aimed at lowering inflammation

    STAT News

    STAT+: Novo Nordisk stops two cardiovascular trials of drug aimed at lowering inflammation

    7 September 2026

Related Insights

  • Future Supply Chains, Logistics & Fleets

    The Supply Chain That Thinks - How AI agents, quantum computing, cheap energy and programmable risk could reshape global logistics, 2026–2036

    9 Sept 202619 min read
  • Synthetic biology and bioengineering

    The Bio Revolution Is Here — And the World Is Already Choosing Sides

    Biology is becoming the next great industrial platform — accelerated by AI, contested by China and the US, and creating tomorrow's careers.

    8 Sept 202615 min read
  • Quantum computing

    The race to master quantum computing could reshape medicine, energy and security.

    8 Sept 202623 min read
Browse all insights →

Related Events

  • Project Finance & Project Financial Modelling - Oct 2026

    19 Oct 2025
  • Autonomous e-Mobility Forum 2026

    7 Sept 2026
    Qatar
  • Saudi Warehousing & Logistics Expo 2026

    8 Sept 2026
    Riyadh, Saudi Arabia
  • FIBO Arabia 2026

    8 Sept 2026
    Riyadh, Saudi Arabia
Browse All Events→

More From The Newsroom

  • STAT+: UnitedHealth’s Democrat investment, and surprise billing bloat debate

    STAT+: UnitedHealth’s Democrat investment, and surprise billing bloat debate

    8 September 2026
  • STAT+: Novartis’ experimental cardiovascular drug fails a pivotal study

    STAT+: Novartis’ experimental cardiovascular drug fails a pivotal study

    4 September 2026
  • STAT+: FDA warns an API supplier about residue on walls, a corroded product line, and open-toed sandals

    STAT+: FDA warns an API supplier about residue on walls, a corroded product line, and open-toed sandals

    8 September 2026
  • STAT+: After failure of Angelman syndrome drug, experts see hope in other experimental therapies

    STAT+: After failure of Angelman syndrome drug, experts see hope in other experimental therapies

    4 September 2026
Industry Events

The world's most trusted B2B event discovery platform. Connecting industry professionals with the conferences, expos and summits that matter.

Explore & Services
  • Industry Events
  • News
  • Event Organisers
  • About Us
  • Our Services
  • Premium Organiser
  • Event Pro
  • Become a Speaker
  • Subscribe
Legal & Privacy
  • Terms
  • Privacy

© 2026 Industry Events Worldwide. All rights reserved.

VF103.4.
Industry Events

The world's most trusted B2B event discovery platform. Connecting industry professionals with the conferences, expos and summits that matter.

  • Industry Events
  • News
  • Event Organisers
  • About Us
  • Our Services
  • Premium Organiser
  • Event Pro
  • Become a Speaker
  • Subscribe
  • Terms
  • Privacy

© 2026 Industry Events Worldwide. All rights reserved.

VF103.4.